Evidence map›Paper›PMID 36644855›Full record

ArticleArchives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists2023

Item Response Analysis of the Financial Capacity Instrument-Short Form.

Adam Gerstenecker, Richard Kennedy, Yue Zhang, Roy C Martin, R Scott Mackin, Michael W Weiner, Taylor Howell, Ronald C Petersen, Erik D Roberson, Daniel C Marson

Abstract read
In one paragraph

Article in Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Adam GersteneckerDepartment of Neurology, University of Alabama at Birmingham, San Francisco, CA, USA.
Richard KennedyAlzheimer's Disease Center, University of Alabama at Birmingham, San Francisco, CA, USA.
Yue ZhangDivision of Gerontology, Geriatrics, and Palliative Care, Department of Medicine, University of Alabama at Birmingham, San Francisco, CA, USA.
Roy C MartinDepartment of Neurology, University of Alabama at Birmingham, San Francisco, CA, USA.
R Scott MackinDepartment of Psychiatry, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.
Michael W WeinerSan Francisco Veteran's Administration Medical Center, San Francisco, CA, USA.
Taylor HowellDepartment of Psychiatry, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.
Ronald C PetersenDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.
Erik D RobersonDepartment of Neurology, University of Alabama at Birmingham, San Francisco, CA, USA.
Daniel C MarsonDepartment of Neurology, University of Alabama at Birmingham, San Francisco, CA, USA.

Funding

SUPPLEMENT TO ALZHEIMERS DISEASE PATIENT REGISTRYU01AG006786 · NIA · MAYO CLINIC ROCHESTER · PI GRAFF-RADFORD, JONATHAN, JACK, CLIFFORD R. · 1986 to 2023
$49.6M
Rochester Epidemiology ProjectR01AG034676 · NIA · MAYO CLINIC ROCHESTER · PI ROCCA, WALTER A, ST SAUVER, JENNIFER LYNN · 2010 to 2019
$9.5M
Validation of Online Methods to Predict and Monitor Cognitive DeclineRF1AG059009 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI NOSHENY, RACHEL LAUREN · 2018 to 2018
$6.2M
Functional Change in Mild Cognitive ImpairmentR01AG021927 · NIA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MARSON, DANIEL C · 2004 to 2014
$4.4M
The Brain Health Registry for facilitating interdisciplinary aging researchR33AG062867 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI NOSHENY, RACHEL LAUREN · 2020 to 2024
$3.2M
Investigating the Impact of Cognition on Capacity in Multiple SclerosisK23HD091849 · NICHD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GERSTENECKER, ADAM TYLER · 2018 to 2022
$631k
NIA NIH HHS R01 AG021927NIA NIH HHS R01 AG034676NIA NIH HHS R33 AG062867NIA NIH HHS RF1 AG059009NIA NIH HHS U01 AG006786NICHD NIH HHS K23 HD091849NIH HHS K23HD091849
6 · The paper itself

Abstract

objectiveThe Financial Capacity Instrument-Short Form (FCI-SF) is a performance-based measure of everyday financial skills that takes 15 min to administer. Although the FCI-SF has demonstrated excellent psychometric properties, advanced psychometric methods such as item response theory (IRT) can provide important information on the performance of individual test items in measuring financial capacity and in distinguishing between healthy and cognitively impaired individuals.

methodParticipants were 272 older adults diagnosed with mild cognitive impairment (MCI) and 1,344 cognitively healthy controls recruited from the Mayo Clinic Study of Aging at the Mayo Clinic in Rochester, Minnesota and also from the Cognitive Observations in Seniors study at the University of Alabama at Birmingham. Participants in each study were administered the FCI-SF, which evaluates coin/currency calculation, financial conceptual knowledge, use of a checkbook/register, and use of a bank statement.

resultsA unidimensional two-parameter logistic model best fit the 37 FCI-SF Test items, and most FCI-SF items fit the unidimensional two-parameter model well. The results indicated that all FCI-SF items robustly distinguished cognitively healthy controls from persons with MCI.

conclusionsThe study results showed that the FCI-SF performed well under IRT analysis, further highlighted the psychometric properties of the FCI-SF as a valid and reliable measure of financial capacity, and demonstrated the clinical utility of the FCI-SF in distinguishing between cognitively normal and cognitively impaired individuals.

Indexed as

Cognitive DysfunctionAgedAgingHumansNeuropsychological TestsPsychometricsCognitive declineFinancial capacityFinancial capacity instrument-short formItem response theory

Identifiers

PMID36644855
PMCPMC10369359

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.